In this study, we investigated efficacy of KRM-II-81 on DS by using Scn1a deficit mice and illustrated that KRM-II-81 ameliorates hyperthermia-induced seizure susceptibility and anxiety-like behavior in these mice. Here, SCN1A is linked to Dravet syndrome.